Zura Bio Limited
Price Action
Technical Summary
EMERGING TRENDZura Bio Limited is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is moderate (RS Rating: 72), indicating performance broadly in line with the market. Earnings growth of 19% provides fundamental context to the price action. However, price is extended 25% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.01 | +40.40% | ABOVE |
| 50 SMA | $4.52 | +24.63% | ABOVE |
| 100 SMA | $5.35 | +5.21% | ABOVE |
| 150 SMA | $5.15 | +9.27% | ABOVE |
| 200 SMA | $4.72 | +19.40% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ZURA in an uptrend right now?
ZURA has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is ZURA overbought or oversold?
ZURA's RSI (14) is 71. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is ZURA outperforming the market?
ZURA has a Relative Strength (RS) Rating of 72 out of 99. ZURA is performing about average compared to the market.
Where is ZURA in its 52-week range?
ZURA is trading at $5.63, which is 76% of its 52-week high ($7.44) and 72% above its 52-week low ($1.00).
How volatile is ZURA?
ZURA has a Beta of 1.69 and 52-week volatility of 111%. It's more volatile than the S&P 500 - expect bigger swings.